English

ACORDA THERAPEUTICS INC

EDGAR

ACOR Quarterly report (10-Q) · filed 2024-05-14

270 filing records in this dataset, filed from 2006-03-31 to 2024-05-14. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

20.3 million USD

2024 Q1 · USD

Exact inputs and evidence

Revenue: 20289000 USD Source

Operating margin

-96.74%

2024 Q1 · %

Exact inputs and evidence

Operating Income: -19628000 USD Source
Revenue: 20289000 USD Source

Operating cash flow

-20.2 million USD

2024 Q1 · USD

Exact inputs and evidence

Operating Cash Flow: -20185000 USD Source

Cash and cash equivalents: 9.36 million USD 2024-03-31 Source
Exact value

9364000 USD
Long-term debt including current maturities: 151 million USD 2021-12-31 Source
Exact value

151025000 USD
Shares outstanding: 45.7 million shares 2016-12-31 Source
Exact value

45680042 shares

Reported share-count change

6.23% · 2.68 million shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

42999377 shares · 2015-12-31· Source
45680042 shares · 2016-12-31· Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2024-05-14.

Financial data available through: 2023-12-31.

Coverage by financial measure

Revenue: 11 of 11 periods available· newest 2023-12-31
Operating income: 11 of 11 periods available· newest 2023-12-31
Net income: 11 of 11 periods available· newest 2023-12-31
Operating cash flow: 11 of 11 periods available· newest 2023-12-31
Capital expenditure: 11 of 11 periods available· newest 2023-12-31
Total assets: 10 of 11 periods available· newest 2023-12-31
liabilities: No compatible figures in this window
Current assets: 10 of 11 periods available· newest 2023-12-31
Current liabilities: 10 of 11 periods available· newest 2023-12-31
Cash and cash equivalents: 11 of 11 periods available· newest 2023-12-31
Long-term debt including current maturities: 1 of 11 periods available· newest 2021-12-31
Shares outstanding: 3 of 11 periods available· newest 2016-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
-0.8%

Prior period

USD 118.57 million

2022-01-01 – 2022-12-31
Current period

USD 117.63 million

2023-01-01 – 2023-12-31

Exact inputs and evidence

117633000 − 118566000 = -933000 USD

118566000 USD · 2022-01-01 – 2022-12-31
Inspect prior input Prior source
117633000 USD · 2023-01-01 – 2023-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · ACORDA THERAPEUTICS INC · 2023-12-31 ACORDA THERAPEUTICS INC (edgar:1008848) Year-over-year change in Revenue: -933000 USD Concept: fundies:Revenue Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T16:57:15Z Snapshot: 748ac4fe79b8cf4dbe84212e0f2cc038fc8affdab4189df0d492e45d50522821 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1008848?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 117633000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1008848/000095017024039464/acor-20231231.htm#1871349 Filing: 000095017024039464 Input fundies:Revenue: 118566000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1008848/000095017024039464/acor-20231231.htm#1872727 Filing: 000095017024039464
The citation records this snapshot. The page link may show a newer release later.
Net income
−USD 186.94 million

Prior period

−USD 65.92 million

2022-01-01 – 2022-12-31
Current period

−USD 252.85 million

2023-01-01 – 2023-12-31

Exact inputs and evidence

-252854000 − -65916000 = -186938000 USD

-65916000 USD · 2022-01-01 – 2022-12-31
Inspect prior input Prior source
-252854000 USD · 2023-01-01 – 2023-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · ACORDA THERAPEUTICS INC · 2023-12-31 ACORDA THERAPEUTICS INC (edgar:1008848) Year-over-year change in Net income: -186938000 USD Concept: fundies:NetIncome Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T16:57:15Z Snapshot: 748ac4fe79b8cf4dbe84212e0f2cc038fc8affdab4189df0d492e45d50522821 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1008848?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -252854000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1008848/000095017024039464/acor-20231231.htm#2928083 Filing: 000095017024039464 Input fundies:NetIncome: -65916000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1008848/000095017024039464/acor-20231231.htm#2929385 Filing: 000095017024039464
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+USD 6.94 million

Prior period

−USD 20.92 million

2022-01-01 – 2022-12-31
Current period

−USD 13.98 million

2023-01-01 – 2023-12-31

Exact inputs and evidence

-13984000 − -20924000 = 6940000 USD

-20924000 USD · 2022-01-01 – 2022-12-31
Inspect prior input Prior source
-13984000 USD · 2023-01-01 – 2023-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · ACORDA THERAPEUTICS INC · 2023-12-31 ACORDA THERAPEUTICS INC (edgar:1008848) Year-over-year change in Operating cash flow: 6940000 USD Concept: fundies:OperatingCashFlow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T16:57:15Z Snapshot: 748ac4fe79b8cf4dbe84212e0f2cc038fc8affdab4189df0d492e45d50522821 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1008848?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -13984000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1008848/000095017024039464/acor-20231231.htm#1654398 Filing: 000095017024039464 Input fundies:OperatingCashFlow: -20924000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1008848/000095017024039464/acor-20231231.htm#1655738 Filing: 000095017024039464
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
+94.1%

Prior period

USD 136,000

2022-01-01 – 2022-12-31
Current period

USD 264,000

2023-01-01 – 2023-12-31

Exact inputs and evidence

264000 − 136000 = 128000 USD

136000 USD · 2022-01-01 – 2022-12-31
Inspect prior input Prior source
264000 USD · 2023-01-01 – 2023-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · ACORDA THERAPEUTICS INC · 2023-12-31 ACORDA THERAPEUTICS INC (edgar:1008848) Year-over-year change in Capital expenditure: 128000 USD Concept: fundies:CapitalExpenditure Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T16:57:15Z Snapshot: 748ac4fe79b8cf4dbe84212e0f2cc038fc8affdab4189df0d492e45d50522821 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1008848?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 264000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1008848/000095017024039464/acor-20231231.htm#1659354 Filing: 000095017024039464 Input fundies:CapitalExpenditure: 136000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1008848/000095017024039464/acor-20231231.htm#1660786 Filing: 000095017024039464
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2023 2023-01-01 – 2023-12-31

Revenue USD 117.63 million 100% of revenue
Cost of revenue USD 15.28 million 13% of revenue
Operating expenses USD 94.85 million 81% of revenue
Other operating costs Derived USD 272.45 million 232% of revenue
Operating income −USD 264.95 million −225% of revenue
Tax, interest and other Derived −USD 12.1 million −10% of revenue
Net income −USD 252.85 million −215% of revenue

Cash

Operating cash flow −USD 13.98 million −12% of revenue
Capital expenditure USD 264,000 0.2% of revenue
Free cash flow Derived −USD 14.25 million −12% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2014 91%
2015 93%
2016 Operating loss: operating costs were 107% of revenue.
2017 Operating loss: operating costs were 140% of revenue.
2018 92%
2019 Operating loss: operating costs were 262% of revenue.
2020 Operating loss: operating costs were 151% of revenue.
2021 Operating loss: operating costs were 161% of revenue.
2022 Operating loss: operating costs were 130% of revenue.
2023 Operating loss: operating costs were 325% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2014 2014-01-01 – 2014-12-31	401480000	365089000 Derived	36391000	18719000 Derived	17672000	69565000 Derived	Source 2014-01-01 – 2014-12-31: 401480000 USD Inspect Revenue Open source 2014-01-01 – 2014-12-31: 36391000 USD Inspect Operating Income Open source 2014-01-01 – 2014-12-31: 17672000 USD Inspect Net Income Open source 2014-01-01 – 2014-12-31: 74649000 USD Inspect Operating Cash Flow Open source 2014-01-01 – 2014-12-31: 5084000 USD Inspect Capital Expenditure Open source
2015 2015-01-01 – 2015-12-31	492660000	458670000 Derived	33990000	22932000 Derived	11058000	32560000 Derived	Source 2015-01-01 – 2015-12-31: 492660000 USD Inspect Revenue Open source 2015-01-01 – 2015-12-31: 33990000 USD Inspect Operating Income Open source 2015-01-01 – 2015-12-31: 11058000 USD Inspect Net Income Open source 2015-01-01 – 2015-12-31: 38481000 USD Inspect Operating Cash Flow Open source 2015-01-01 – 2015-12-31: 5921000 USD Inspect Capital Expenditure Open source
2016 2016-01-01 – 2016-12-31	519601000	555583000 Derived	-35982000	-1364000 Derived	-34618000	23457000 Derived	Source 2016-01-01 – 2016-12-31: 519601000 USD Inspect Revenue Open source 2016-01-01 – 2016-12-31: -35982000 USD Inspect Operating Income Open source 2016-01-01 – 2016-12-31: -34618000 USD Inspect Net Income Open source 2016-01-01 – 2016-12-31: 29649000 USD Inspect Operating Cash Flow Open source 2016-01-01 – 2016-12-31: 6192000 USD Inspect Capital Expenditure Open source
2017 2017-01-01 – 2017-12-31	588287000	821101000 Derived	-232814000	-9455000 Derived	-223359000	83448000 Derived	Source 2017-01-01 – 2017-12-31: 588287000 USD Inspect Revenue Open source 2017-01-01 – 2017-12-31: -232814000 USD Inspect Operating Income Open source 2017-01-01 – 2017-12-31: -223359000 USD Inspect Net Income Open source 2017-01-01 – 2017-12-31: 97136000 USD Inspect Operating Cash Flow Open source 2017-01-01 – 2017-12-31: 13688000 USD Inspect Capital Expenditure Open source
2018 2018-01-01 – 2018-12-31	471433000	432947000 Derived	38486000	4804000 Derived	33682000	117465000 Derived	Source 2018-01-01 – 2018-12-31: 471433000 USD Inspect Revenue Open source 2018-01-01 – 2018-12-31: 38486000 USD Inspect Operating Income Open source 2018-01-01 – 2018-12-31: 33682000 USD Inspect Net Income Open source 2018-01-01 – 2018-12-31: 150793000 USD Inspect Operating Cash Flow Open source 2018-01-01 – 2018-12-31: 33328000 USD Inspect Capital Expenditure Open source
2019 2019-01-01 – 2019-12-31	192408000	504040000 Derived	-311632000	-38666000 Derived	-272966000	-218593000 Derived	Source 2019-01-01 – 2019-12-31: 192408000 USD Inspect Revenue Open source 2019-01-01 – 2019-12-31: -311632000 USD Inspect Operating Income Open source 2019-01-01 – 2019-12-31: -272966000 USD Inspect Net Income Open source 2019-01-01 – 2019-12-31: -128167000 USD Inspect Operating Cash Flow Open source 2019-01-01 – 2019-12-31: 90426000 USD Inspect Capital Expenditure Open source
2020 2020-01-01 – 2020-12-31	152967000	231043000 Derived	-78076000	21518000 Derived	-99594000	-65396000 Derived	Source 2020-01-01 – 2020-12-31: 152967000 USD Inspect Revenue Open source 2020-01-01 – 2020-12-31: -78076000 USD Inspect Operating Income Open source 2020-01-01 – 2020-12-31: -99594000 USD Inspect Net Income Open source 2020-01-01 – 2020-12-31: -61006000 USD Inspect Operating Cash Flow Open source 2020-01-01 – 2020-12-31: 4390000 USD Inspect Capital Expenditure Open source
2021 2021-01-01 – 2021-12-31	129071000	208109000 Derived	-79038000	24916000 Derived	-103954000	-41513000 Derived	Source 2021-01-01 – 2021-12-31: 129071000 USD Inspect Revenue Open source 2021-01-01 – 2021-12-31: -79038000 USD Inspect Operating Income Open source 2021-01-01 – 2021-12-31: -103954000 USD Inspect Net Income Open source 2021-01-01 – 2021-12-31: -41348000 USD Inspect Operating Cash Flow Open source 2021-01-01 – 2021-12-31: 165000 USD Inspect Capital Expenditure Open source
2022 2022-01-01 – 2022-12-31	118566000	153906000 Derived	-35340000	30576000 Derived	-65916000	-21060000 Derived	Source 2022-01-01 – 2022-12-31: 118566000 USD Inspect Revenue Open source 2022-01-01 – 2022-12-31: -35340000 USD Inspect Operating Income Open source 2022-01-01 – 2022-12-31: -65916000 USD Inspect Net Income Open source 2022-01-01 – 2022-12-31: -20924000 USD Inspect Operating Cash Flow Open source 2022-01-01 – 2022-12-31: 136000 USD Inspect Capital Expenditure Open source
2023 2023-01-01 – 2023-12-31	117633000	382585000 Derived	-264952000	-12098000 Derived	-252854000	-14248000 Derived	Source 2023-01-01 – 2023-12-31: 117633000 USD Inspect Revenue Open source 2023-01-01 – 2023-12-31: -264952000 USD Inspect Operating Income Open source 2023-01-01 – 2023-12-31: -252854000 USD Inspect Net Income Open source 2023-01-01 – 2023-12-31: -13984000 USD Inspect Operating Cash Flow Open source 2023-01-01 – 2023-12-31: 264000 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 117.6M 2023

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20142014-12-31	Revenue	401480000	Revenue: 401480000 Open source
20152015-12-31	Revenue	492660000	Revenue: 492660000 Open source
20162016-12-31	Revenue	519601000	Revenue: 519601000 Open source
20172017-12-31	Revenue	588287000	Revenue: 588287000 Open source
20182018-12-31	Revenue	471433000	Revenue: 471433000 Open source
20192019-12-31	Revenue	192408000	Revenue: 192408000 Open source
20202020-12-31	Revenue	152967000	Revenue: 152967000 Open source
20212021-12-31	Revenue	129071000	Revenue: 129071000 Open source
20222022-12-31	Revenue	118566000	Revenue: 118566000 Open source
20232023-12-31	Revenue	117633000	Revenue: 117633000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

-0.8% 2023

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20142014-12-31	Year over year	19.3%	Revenue: 401480000 Open source Revenue: 336430000 Open source
20152015-12-31	Year over year	22.7%	Revenue: 492660000 Open source Revenue: 401480000 Open source
20162016-12-31	Year over year	5.5%	Revenue: 519601000 Open source Revenue: 492660000 Open source
20172017-12-31	Year over year	13.2%	Revenue: 588287000 Open source Revenue: 519601000 Open source
20182018-12-31	Year over year	-19.9%	Revenue: 471433000 Open source Revenue: 588287000 Open source
20192019-12-31	Year over year	-59.2%	Revenue: 192408000 Open source Revenue: 471433000 Open source
20202020-12-31	Year over year	-20.5%	Revenue: 152967000 Open source Revenue: 192408000 Open source
20212021-12-31	Year over year	-15.6%	Revenue: 129071000 Open source Revenue: 152967000 Open source
20222022-12-31	Year over year	-8.1%	Revenue: 118566000 Open source Revenue: 129071000 Open source
20232023-12-31	Year over year	-0.8%	Revenue: 117633000 Open source Revenue: 118566000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -225.2% 2023

Net margin -215% 2023

Free cash flow margin -12.1% 2023

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20142014-12-31	Operating margin	9.1%	Operating Income: 36391000 Open source Revenue: 401480000 Open source
20152015-12-31	Operating margin	6.9%	Operating Income: 33990000 Open source Revenue: 492660000 Open source
20162016-12-31	Operating margin	-6.9%	Operating Income: -35982000 Open source Revenue: 519601000 Open source
20172017-12-31	Operating margin	-39.6%	Operating Income: -232814000 Open source Revenue: 588287000 Open source
20182018-12-31	Operating margin	8.2%	Operating Income: 38486000 Open source Revenue: 471433000 Open source
20192019-12-31	Operating margin	-162%	Operating Income: -311632000 Open source Revenue: 192408000 Open source
20202020-12-31	Operating margin	-51%	Operating Income: -78076000 Open source Revenue: 152967000 Open source
20212021-12-31	Operating margin	-61.2%	Operating Income: -79038000 Open source Revenue: 129071000 Open source
20222022-12-31	Operating margin	-29.8%	Operating Income: -35340000 Open source Revenue: 118566000 Open source
20232023-12-31	Operating margin	-225.2%	Operating Income: -264952000 Open source Revenue: 117633000 Open source
20142014-12-31	Net margin	4.4%	Net Income: 17672000 Open source Revenue: 401480000 Open source
20152015-12-31	Net margin	2.2%	Net Income: 11058000 Open source Revenue: 492660000 Open source
20162016-12-31	Net margin	-6.7%	Net Income: -34618000 Open source Revenue: 519601000 Open source
20172017-12-31	Net margin	-38%	Net Income: -223359000 Open source Revenue: 588287000 Open source
20182018-12-31	Net margin	7.1%	Net Income: 33682000 Open source Revenue: 471433000 Open source
20192019-12-31	Net margin	-141.9%	Net Income: -272966000 Open source Revenue: 192408000 Open source
20202020-12-31	Net margin	-65.1%	Net Income: -99594000 Open source Revenue: 152967000 Open source
20212021-12-31	Net margin	-80.5%	Net Income: -103954000 Open source Revenue: 129071000 Open source
20222022-12-31	Net margin	-55.6%	Net Income: -65916000 Open source Revenue: 118566000 Open source
20232023-12-31	Net margin	-215%	Net Income: -252854000 Open source Revenue: 117633000 Open source
20142014-12-31	Free cash flow margin	17.3%	Revenue: 401480000 Open source Operating Cash Flow: 74649000 Open source Capital Expenditure: 5084000 Open source
20152015-12-31	Free cash flow margin	6.6%	Revenue: 492660000 Open source Operating Cash Flow: 38481000 Open source Capital Expenditure: 5921000 Open source
20162016-12-31	Free cash flow margin	4.5%	Revenue: 519601000 Open source Operating Cash Flow: 29649000 Open source Capital Expenditure: 6192000 Open source
20172017-12-31	Free cash flow margin	14.2%	Revenue: 588287000 Open source Operating Cash Flow: 97136000 Open source Capital Expenditure: 13688000 Open source
20182018-12-31	Free cash flow margin	24.9%	Revenue: 471433000 Open source Operating Cash Flow: 150793000 Open source Capital Expenditure: 33328000 Open source
20192019-12-31	Free cash flow margin	-113.6%	Revenue: 192408000 Open source Operating Cash Flow: -128167000 Open source Capital Expenditure: 90426000 Open source
20202020-12-31	Free cash flow margin	-42.8%	Revenue: 152967000 Open source Operating Cash Flow: -61006000 Open source Capital Expenditure: 4390000 Open source
20212021-12-31	Free cash flow margin	-32.2%	Revenue: 129071000 Open source Operating Cash Flow: -41348000 Open source Capital Expenditure: 165000 Open source
20222022-12-31	Free cash flow margin	-17.8%	Revenue: 118566000 Open source Operating Cash Flow: -20924000 Open source Capital Expenditure: 136000 Open source
20232023-12-31	Free cash flow margin	-12.1%	Revenue: 117633000 Open source Operating Cash Flow: -13984000 Open source Capital Expenditure: 264000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -14M 2023

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20142014-12-31	Operating cash flow	74649000	Operating Cash Flow: 74649000 Open source
20152015-12-31	Operating cash flow	38481000	Operating Cash Flow: 38481000 Open source
20162016-12-31	Operating cash flow	29649000	Operating Cash Flow: 29649000 Open source
20172017-12-31	Operating cash flow	97136000	Operating Cash Flow: 97136000 Open source
20182018-12-31	Operating cash flow	150793000	Operating Cash Flow: 150793000 Open source
20192019-12-31	Operating cash flow	-128167000	Operating Cash Flow: -128167000 Open source
20202020-12-31	Operating cash flow	-61006000	Operating Cash Flow: -61006000 Open source
20212021-12-31	Operating cash flow	-41348000	Operating Cash Flow: -41348000 Open source
20222022-12-31	Operating cash flow	-20924000	Operating Cash Flow: -20924000 Open source
20232023-12-31	Operating cash flow	-13984000	Operating Cash Flow: -13984000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -14.2M 2023

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20142014-12-31	Free cash flow	69565000	Operating Cash Flow: 74649000 Open source Capital Expenditure: 5084000 Open source
20152015-12-31	Free cash flow	32560000	Operating Cash Flow: 38481000 Open source Capital Expenditure: 5921000 Open source
20162016-12-31	Free cash flow	23457000	Operating Cash Flow: 29649000 Open source Capital Expenditure: 6192000 Open source
20172017-12-31	Free cash flow	83448000	Operating Cash Flow: 97136000 Open source Capital Expenditure: 13688000 Open source
20182018-12-31	Free cash flow	117465000	Operating Cash Flow: 150793000 Open source Capital Expenditure: 33328000 Open source
20192019-12-31	Free cash flow	-218593000	Operating Cash Flow: -128167000 Open source Capital Expenditure: 90426000 Open source
20202020-12-31	Free cash flow	-65396000	Operating Cash Flow: -61006000 Open source Capital Expenditure: 4390000 Open source
20212021-12-31	Free cash flow	-41513000	Operating Cash Flow: -41348000 Open source Capital Expenditure: 165000 Open source
20222022-12-31	Free cash flow	-21060000	Operating Cash Flow: -20924000 Open source Capital Expenditure: 136000 Open source
20232023-12-31	Free cash flow	-14248000	Operating Cash Flow: -13984000 Open source Capital Expenditure: 264000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
2014-12-31	Liabilities / assets	Not reported	No source recorded
2015-12-31	Liabilities / assets	Not reported	Total Assets: 1111294000 Open source
2016-12-31	Liabilities / assets	Not reported	Total Assets: 1342335000 Open source
2017-12-31	Liabilities / assets	Not reported	Total Assets: 1197969000 Open source
2018-12-31	Liabilities / assets	Not reported	Total Assets: 1299666000 Open source
2019-12-31	Liabilities / assets	Not reported	Total Assets: 799718000 Open source
2020-12-31	Liabilities / assets	Not reported	Total Assets: 632680000 Open source
2021-12-31	Liabilities / assets	Not reported	Total Assets: 455470000 Open source
2022-12-31	Liabilities / assets	Not reported	Total Assets: 395595000 Open source
2023-12-31	Liabilities / assets	Not reported	Total Assets: 108525000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

0.33× 2023

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
2014-12-31	Current assets / current liabilities	Not reported	No source recorded
20152015-12-31	Current assets / current liabilities	4.98×	Current Assets: 451317000 Open source Current Liabilities: 90592000 Open source
20162016-12-31	Current assets / current liabilities	1.84×	Current Assets: 272657000 Open source Current Liabilities: 147901000 Open source
20172017-12-31	Current assets / current liabilities	3.07×	Current Assets: 441698000 Open source Current Liabilities: 143960000 Open source
20182018-12-31	Current assets / current liabilities	3.77×	Current Assets: 528107000 Open source Current Liabilities: 140256000 Open source
20192019-12-31	Current assets / current liabilities	2.33×	Current Assets: 201113000 Open source Current Liabilities: 86385000 Open source
20202020-12-31	Current assets / current liabilities	1.61×	Current Assets: 221335000 Open source Current Liabilities: 137252000 Open source
20212021-12-31	Current assets / current liabilities	1.89×	Current Assets: 102157000 Open source Current Liabilities: 54025000 Open source
20222022-12-31	Current assets / current liabilities	2.16×	Current Assets: 82115000 Open source Current Liabilities: 37950000 Open source
20232023-12-31	Current assets / current liabilities	0.33×	Current Assets: 74794000 Open source Current Liabilities: 227773000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2014 2014-01-01 – 2014-12-31	USD 17.67 million Exact value Exact value: 17672000 USD 2014-01-01 – 2014-12-31: 17672000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ACORDA THERAPEUTICS INC · 2014-12-31 ACORDA THERAPEUTICS INC (edgar:1008848) Net Income: 17672000 USD Concept: fundies:NetIncome Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T16:57:15Z Snapshot: 748ac4fe79b8cf4dbe84212e0f2cc038fc8affdab4189df0d492e45d50522821 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1008848/explain?concept=fundies%3ANetIncome&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:NetIncome: 17672000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1008848/000156459017002591/acor-20161231.xml#194089 Filing: 000156459017002591 The citation records this snapshot. The page link may show a newer release later.	USD 74.65 million Exact value Exact value: 74649000 USD 2014-01-01 – 2014-12-31: 74649000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ACORDA THERAPEUTICS INC · 2014-12-31 ACORDA THERAPEUTICS INC (edgar:1008848) Operating Cash Flow: 74649000 USD Concept: fundies:OperatingCashFlow Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T16:57:15Z Snapshot: 748ac4fe79b8cf4dbe84212e0f2cc038fc8affdab4189df0d492e45d50522821 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1008848/explain?concept=fundies%3AOperatingCashFlow&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 74649000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1008848/000156459017002591/acor-20161231.xml#235640 Filing: 000156459017002591 The citation records this snapshot. The page link may show a newer release later.	USD 5.08 million Exact value Exact value: 5084000 USD 2014-01-01 – 2014-12-31: 5084000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ACORDA THERAPEUTICS INC · 2014-12-31 ACORDA THERAPEUTICS INC (edgar:1008848) Capital Expenditure: 5084000 USD Concept: fundies:CapitalExpenditure Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T16:57:15Z Snapshot: 748ac4fe79b8cf4dbe84212e0f2cc038fc8affdab4189df0d492e45d50522821 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1008848/explain?concept=fundies%3ACapitalExpenditure&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 5084000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1008848/000156459017002591/acor-20161231.xml#236311 Filing: 000156459017002591 The citation records this snapshot. The page link may show a newer release later.	USD 69.57 million Calculation and evidence 74649000 − 5084000 USD Exact free cash flow: 69565000 USD 2014-01-01 – 2014-12-31: 74649000 USD · Inspect Operating Cash Flow · Source 2014-01-01 – 2014-12-31: 5084000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ACORDA THERAPEUTICS INC · 2014-12-31 ACORDA THERAPEUTICS INC (edgar:1008848) Free cash flow: 69565000 USD Concept: free-cash-flow Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T16:57:15Z Snapshot: 748ac4fe79b8cf4dbe84212e0f2cc038fc8affdab4189df0d492e45d50522821 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1008848?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 74649000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1008848/000156459017002591/acor-20161231.xml#235640 Filing: 000156459017002591 Input fundies:CapitalExpenditure: 5084000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1008848/000156459017002591/acor-20161231.xml#236311 Filing: 000156459017002591 The citation records this snapshot. The page link may show a newer release later.
2015 2015-01-01 – 2015-12-31	USD 11.06 million Exact value Exact value: 11058000 USD 2015-01-01 – 2015-12-31: 11058000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ACORDA THERAPEUTICS INC · 2015-12-31 ACORDA THERAPEUTICS INC (edgar:1008848) Net Income: 11058000 USD Concept: fundies:NetIncome Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T16:57:15Z Snapshot: 748ac4fe79b8cf4dbe84212e0f2cc038fc8affdab4189df0d492e45d50522821 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1008848/explain?concept=fundies%3ANetIncome&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:NetIncome: 11058000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1008848/000156459018005035/acor-20171231.xml#200125 Filing: 000156459018005035 The citation records this snapshot. The page link may show a newer release later.	USD 38.48 million Exact value Exact value: 38481000 USD 2015-01-01 – 2015-12-31: 38481000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ACORDA THERAPEUTICS INC · 2015-12-31 ACORDA THERAPEUTICS INC (edgar:1008848) Operating Cash Flow: 38481000 USD Concept: fundies:OperatingCashFlow Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T16:57:15Z Snapshot: 748ac4fe79b8cf4dbe84212e0f2cc038fc8affdab4189df0d492e45d50522821 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1008848/explain?concept=fundies%3AOperatingCashFlow&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 38481000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1008848/000156459018005035/acor-20171231.xml#242167 Filing: 000156459018005035 The citation records this snapshot. The page link may show a newer release later.	USD 5.92 million Exact value Exact value: 5921000 USD 2015-01-01 – 2015-12-31: 5921000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ACORDA THERAPEUTICS INC · 2015-12-31 ACORDA THERAPEUTICS INC (edgar:1008848) Capital Expenditure: 5921000 USD Concept: fundies:CapitalExpenditure Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T16:57:15Z Snapshot: 748ac4fe79b8cf4dbe84212e0f2cc038fc8affdab4189df0d492e45d50522821 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1008848/explain?concept=fundies%3ACapitalExpenditure&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 5921000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1008848/000156459018005035/acor-20171231.xml#242839 Filing: 000156459018005035 The citation records this snapshot. The page link may show a newer release later.	USD 32.56 million Calculation and evidence 38481000 − 5921000 USD Exact free cash flow: 32560000 USD 2015-01-01 – 2015-12-31: 38481000 USD · Inspect Operating Cash Flow · Source 2015-01-01 – 2015-12-31: 5921000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ACORDA THERAPEUTICS INC · 2015-12-31 ACORDA THERAPEUTICS INC (edgar:1008848) Free cash flow: 32560000 USD Concept: free-cash-flow Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T16:57:15Z Snapshot: 748ac4fe79b8cf4dbe84212e0f2cc038fc8affdab4189df0d492e45d50522821 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1008848?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 38481000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1008848/000156459018005035/acor-20171231.xml#242167 Filing: 000156459018005035 Input fundies:CapitalExpenditure: 5921000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1008848/000156459018005035/acor-20171231.xml#242839 Filing: 000156459018005035 The citation records this snapshot. The page link may show a newer release later.
2016 2016-01-01 – 2016-12-31	−USD 34.62 million Exact value Exact value: -34618000 USD 2016-01-01 – 2016-12-31: -34618000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ACORDA THERAPEUTICS INC · 2016-12-31 ACORDA THERAPEUTICS INC (edgar:1008848) Net Income: -34618000 USD Concept: fundies:NetIncome Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T16:57:15Z Snapshot: 748ac4fe79b8cf4dbe84212e0f2cc038fc8affdab4189df0d492e45d50522821 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1008848/explain?concept=fundies%3ANetIncome&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:NetIncome: -34618000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1008848/000156459019004986/acor-20181231.xml#214959 Filing: 000156459019004986 The citation records this snapshot. The page link may show a newer release later.	USD 29.65 million Exact value Exact value: 29649000 USD 2016-01-01 – 2016-12-31: 29649000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ACORDA THERAPEUTICS INC · 2016-12-31 ACORDA THERAPEUTICS INC (edgar:1008848) Operating Cash Flow: 29649000 USD Concept: fundies:OperatingCashFlow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T16:57:15Z Snapshot: 748ac4fe79b8cf4dbe84212e0f2cc038fc8affdab4189df0d492e45d50522821 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1008848/explain?concept=fundies%3AOperatingCashFlow&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 29649000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1008848/000156459019004986/acor-20181231.xml#256756 Filing: 000156459019004986 The citation records this snapshot. The page link may show a newer release later.	USD 6.19 million Exact value Exact value: 6192000 USD 2016-01-01 – 2016-12-31: 6192000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ACORDA THERAPEUTICS INC · 2016-12-31 ACORDA THERAPEUTICS INC (edgar:1008848) Capital Expenditure: 6192000 USD Concept: fundies:CapitalExpenditure Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T16:57:15Z Snapshot: 748ac4fe79b8cf4dbe84212e0f2cc038fc8affdab4189df0d492e45d50522821 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1008848/explain?concept=fundies%3ACapitalExpenditure&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 6192000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1008848/000156459019004986/acor-20181231.xml#257389 Filing: 000156459019004986 The citation records this snapshot. The page link may show a newer release later.	USD 23.46 million Calculation and evidence 29649000 − 6192000 USD Exact free cash flow: 23457000 USD 2016-01-01 – 2016-12-31: 29649000 USD · Inspect Operating Cash Flow · Source 2016-01-01 – 2016-12-31: 6192000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ACORDA THERAPEUTICS INC · 2016-12-31 ACORDA THERAPEUTICS INC (edgar:1008848) Free cash flow: 23457000 USD Concept: free-cash-flow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T16:57:15Z Snapshot: 748ac4fe79b8cf4dbe84212e0f2cc038fc8affdab4189df0d492e45d50522821 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1008848?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 29649000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1008848/000156459019004986/acor-20181231.xml#256756 Filing: 000156459019004986 Input fundies:CapitalExpenditure: 6192000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1008848/000156459019004986/acor-20181231.xml#257389 Filing: 000156459019004986 The citation records this snapshot. The page link may show a newer release later.
2017 2017-01-01 – 2017-12-31	−USD 223.36 million Exact value Exact value: -223359000 USD 2017-01-01 – 2017-12-31: -223359000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ACORDA THERAPEUTICS INC · 2017-12-31 ACORDA THERAPEUTICS INC (edgar:1008848) Net Income: -223359000 USD Concept: fundies:NetIncome Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T16:57:15Z Snapshot: 748ac4fe79b8cf4dbe84212e0f2cc038fc8affdab4189df0d492e45d50522821 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1008848/explain?concept=fundies%3ANetIncome&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:NetIncome: -223359000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1008848/000156459020007789/acor-10k_20191231.htm#4942581 Filing: 000156459020007789 The citation records this snapshot. The page link may show a newer release later.	USD 97.14 million Exact value Exact value: 97136000 USD 2017-01-01 – 2017-12-31: 97136000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ACORDA THERAPEUTICS INC · 2017-12-31 ACORDA THERAPEUTICS INC (edgar:1008848) Operating Cash Flow: 97136000 USD Concept: fundies:OperatingCashFlow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T16:57:15Z Snapshot: 748ac4fe79b8cf4dbe84212e0f2cc038fc8affdab4189df0d492e45d50522821 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1008848/explain?concept=fundies%3AOperatingCashFlow&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 97136000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1008848/000156459020007789/acor-10k_20191231.htm#2820133 Filing: 000156459020007789 The citation records this snapshot. The page link may show a newer release later.	USD 13.69 million Exact value Exact value: 13688000 USD 2017-01-01 – 2017-12-31: 13688000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ACORDA THERAPEUTICS INC · 2017-12-31 ACORDA THERAPEUTICS INC (edgar:1008848) Capital Expenditure: 13688000 USD Concept: fundies:CapitalExpenditure Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T16:57:15Z Snapshot: 748ac4fe79b8cf4dbe84212e0f2cc038fc8affdab4189df0d492e45d50522821 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1008848/explain?concept=fundies%3ACapitalExpenditure&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 13688000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1008848/000156459020007789/acor-10k_20191231.htm#2831008 Filing: 000156459020007789 The citation records this snapshot. The page link may show a newer release later.	USD 83.45 million Calculation and evidence 97136000 − 13688000 USD Exact free cash flow: 83448000 USD 2017-01-01 – 2017-12-31: 97136000 USD · Inspect Operating Cash Flow · Source 2017-01-01 – 2017-12-31: 13688000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ACORDA THERAPEUTICS INC · 2017-12-31 ACORDA THERAPEUTICS INC (edgar:1008848) Free cash flow: 83448000 USD Concept: free-cash-flow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T16:57:15Z Snapshot: 748ac4fe79b8cf4dbe84212e0f2cc038fc8affdab4189df0d492e45d50522821 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1008848?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 97136000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1008848/000156459020007789/acor-10k_20191231.htm#2820133 Filing: 000156459020007789 Input fundies:CapitalExpenditure: 13688000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1008848/000156459020007789/acor-10k_20191231.htm#2831008 Filing: 000156459020007789 The citation records this snapshot. The page link may show a newer release later.
2018 2018-01-01 – 2018-12-31	USD 33.68 million Exact value Exact value: 33682000 USD 2018-01-01 – 2018-12-31: 33682000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ACORDA THERAPEUTICS INC · 2018-12-31 ACORDA THERAPEUTICS INC (edgar:1008848) Net Income: 33682000 USD Concept: fundies:NetIncome Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T16:57:15Z Snapshot: 748ac4fe79b8cf4dbe84212e0f2cc038fc8affdab4189df0d492e45d50522821 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1008848/explain?concept=fundies%3ANetIncome&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:NetIncome: 33682000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1008848/000156459020007789/acor-10k_20191231.htm#4940831 Filing: 000156459020007789 The citation records this snapshot. The page link may show a newer release later.	USD 150.79 million Exact value Exact value: 150793000 USD 2018-01-01 – 2018-12-31: 150793000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ACORDA THERAPEUTICS INC · 2018-12-31 ACORDA THERAPEUTICS INC (edgar:1008848) Operating Cash Flow: 150793000 USD Concept: fundies:OperatingCashFlow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T16:57:15Z Snapshot: 748ac4fe79b8cf4dbe84212e0f2cc038fc8affdab4189df0d492e45d50522821 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1008848/explain?concept=fundies%3AOperatingCashFlow&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 150793000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1008848/000156459020007789/acor-10k_20191231.htm#2818279 Filing: 000156459020007789 The citation records this snapshot. The page link may show a newer release later.	USD 33.33 million Exact value Exact value: 33328000 USD 2018-01-01 – 2018-12-31: 33328000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ACORDA THERAPEUTICS INC · 2018-12-31 ACORDA THERAPEUTICS INC (edgar:1008848) Capital Expenditure: 33328000 USD Concept: fundies:CapitalExpenditure Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T16:57:15Z Snapshot: 748ac4fe79b8cf4dbe84212e0f2cc038fc8affdab4189df0d492e45d50522821 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1008848/explain?concept=fundies%3ACapitalExpenditure&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 33328000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1008848/000156459020007789/acor-10k_20191231.htm#2829225 Filing: 000156459020007789 The citation records this snapshot. The page link may show a newer release later.	USD 117.47 million Calculation and evidence 150793000 − 33328000 USD Exact free cash flow: 117465000 USD 2018-01-01 – 2018-12-31: 150793000 USD · Inspect Operating Cash Flow · Source 2018-01-01 – 2018-12-31: 33328000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ACORDA THERAPEUTICS INC · 2018-12-31 ACORDA THERAPEUTICS INC (edgar:1008848) Free cash flow: 117465000 USD Concept: free-cash-flow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T16:57:15Z Snapshot: 748ac4fe79b8cf4dbe84212e0f2cc038fc8affdab4189df0d492e45d50522821 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1008848?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 150793000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1008848/000156459020007789/acor-10k_20191231.htm#2818279 Filing: 000156459020007789 Input fundies:CapitalExpenditure: 33328000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1008848/000156459020007789/acor-10k_20191231.htm#2829225 Filing: 000156459020007789 The citation records this snapshot. The page link may show a newer release later.
2019 2019-01-01 – 2019-12-31	−USD 272.97 million Exact value Exact value: -272966000 USD 2019-01-01 – 2019-12-31: -272966000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ACORDA THERAPEUTICS INC · 2019-12-31 ACORDA THERAPEUTICS INC (edgar:1008848) Net Income: -272966000 USD Concept: fundies:NetIncome Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T16:57:15Z Snapshot: 748ac4fe79b8cf4dbe84212e0f2cc038fc8affdab4189df0d492e45d50522821 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1008848/explain?concept=fundies%3ANetIncome&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:NetIncome: -272966000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1008848/000156459021013318/acor-10k_20201231.htm#3938668 Filing: 000156459021013318 The citation records this snapshot. The page link may show a newer release later.	−USD 128.17 million Exact value Exact value: -128167000 USD 2019-01-01 – 2019-12-31: -128167000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ACORDA THERAPEUTICS INC · 2019-12-31 ACORDA THERAPEUTICS INC (edgar:1008848) Operating Cash Flow: -128167000 USD Concept: fundies:OperatingCashFlow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T16:57:15Z Snapshot: 748ac4fe79b8cf4dbe84212e0f2cc038fc8affdab4189df0d492e45d50522821 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1008848/explain?concept=fundies%3AOperatingCashFlow&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -128167000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1008848/000156459021013318/acor-10k_20201231.htm#2217106 Filing: 000156459021013318 The citation records this snapshot. The page link may show a newer release later.	USD 90.43 million Exact value Exact value: 90426000 USD 2019-01-01 – 2019-12-31: 90426000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ACORDA THERAPEUTICS INC · 2019-12-31 ACORDA THERAPEUTICS INC (edgar:1008848) Capital Expenditure: 90426000 USD Concept: fundies:CapitalExpenditure Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T16:57:15Z Snapshot: 748ac4fe79b8cf4dbe84212e0f2cc038fc8affdab4189df0d492e45d50522821 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1008848/explain?concept=fundies%3ACapitalExpenditure&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 90426000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1008848/000156459021013318/acor-10k_20201231.htm#2224638 Filing: 000156459021013318 The citation records this snapshot. The page link may show a newer release later.	−USD 218.59 million Calculation and evidence -128167000 − 90426000 USD Exact free cash flow: -218593000 USD 2019-01-01 – 2019-12-31: -128167000 USD · Inspect Operating Cash Flow · Source 2019-01-01 – 2019-12-31: 90426000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ACORDA THERAPEUTICS INC · 2019-12-31 ACORDA THERAPEUTICS INC (edgar:1008848) Free cash flow: -218593000 USD Concept: free-cash-flow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T16:57:15Z Snapshot: 748ac4fe79b8cf4dbe84212e0f2cc038fc8affdab4189df0d492e45d50522821 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1008848?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -128167000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1008848/000156459021013318/acor-10k_20201231.htm#2217106 Filing: 000156459021013318 Input fundies:CapitalExpenditure: 90426000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1008848/000156459021013318/acor-10k_20201231.htm#2224638 Filing: 000156459021013318 The citation records this snapshot. The page link may show a newer release later.
2020 2020-01-01 – 2020-12-31	−USD 99.59 million Exact value Exact value: -99594000 USD 2020-01-01 – 2020-12-31: -99594000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ACORDA THERAPEUTICS INC · 2020-12-31 ACORDA THERAPEUTICS INC (edgar:1008848) Net Income: -99594000 USD Concept: fundies:NetIncome Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T16:57:15Z Snapshot: 748ac4fe79b8cf4dbe84212e0f2cc038fc8affdab4189df0d492e45d50522821 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1008848/explain?concept=fundies%3ANetIncome&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:NetIncome: -99594000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1008848/000156459022010971/acor-10k_20211231.htm#3586911 Filing: 000156459022010971 The citation records this snapshot. The page link may show a newer release later.	−USD 61.01 million Exact value Exact value: -61006000 USD 2020-01-01 – 2020-12-31: -61006000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ACORDA THERAPEUTICS INC · 2020-12-31 ACORDA THERAPEUTICS INC (edgar:1008848) Operating Cash Flow: -61006000 USD Concept: fundies:OperatingCashFlow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T16:57:15Z Snapshot: 748ac4fe79b8cf4dbe84212e0f2cc038fc8affdab4189df0d492e45d50522821 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1008848/explain?concept=fundies%3AOperatingCashFlow&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -61006000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1008848/000156459022010971/acor-10k_20211231.htm#2017212 Filing: 000156459022010971 The citation records this snapshot. The page link may show a newer release later.	USD 4.39 million Exact value Exact value: 4390000 USD 2020-01-01 – 2020-12-31: 4390000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ACORDA THERAPEUTICS INC · 2020-12-31 ACORDA THERAPEUTICS INC (edgar:1008848) Capital Expenditure: 4390000 USD Concept: fundies:CapitalExpenditure Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T16:57:15Z Snapshot: 748ac4fe79b8cf4dbe84212e0f2cc038fc8affdab4189df0d492e45d50522821 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1008848/explain?concept=fundies%3ACapitalExpenditure&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 4390000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1008848/000156459022010971/acor-10k_20211231.htm#2024718 Filing: 000156459022010971 The citation records this snapshot. The page link may show a newer release later.	−USD 65.4 million Calculation and evidence -61006000 − 4390000 USD Exact free cash flow: -65396000 USD 2020-01-01 – 2020-12-31: -61006000 USD · Inspect Operating Cash Flow · Source 2020-01-01 – 2020-12-31: 4390000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ACORDA THERAPEUTICS INC · 2020-12-31 ACORDA THERAPEUTICS INC (edgar:1008848) Free cash flow: -65396000 USD Concept: free-cash-flow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T16:57:15Z Snapshot: 748ac4fe79b8cf4dbe84212e0f2cc038fc8affdab4189df0d492e45d50522821 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1008848?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -61006000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1008848/000156459022010971/acor-10k_20211231.htm#2017212 Filing: 000156459022010971 Input fundies:CapitalExpenditure: 4390000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1008848/000156459022010971/acor-10k_20211231.htm#2024718 Filing: 000156459022010971 The citation records this snapshot. The page link may show a newer release later.
2021 2021-01-01 – 2021-12-31	−USD 103.95 million Exact value Exact value: -103954000 USD 2021-01-01 – 2021-12-31: -103954000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ACORDA THERAPEUTICS INC · 2021-12-31 ACORDA THERAPEUTICS INC (edgar:1008848) Net Income: -103954000 USD Concept: fundies:NetIncome Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T16:57:15Z Snapshot: 748ac4fe79b8cf4dbe84212e0f2cc038fc8affdab4189df0d492e45d50522821 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1008848/explain?concept=fundies%3ANetIncome&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:NetIncome: -103954000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1008848/000095017023007948/acor-20221231.htm#4037219 Filing: 000095017023007948 The citation records this snapshot. The page link may show a newer release later.	−USD 41.35 million Exact value Exact value: -41348000 USD 2021-01-01 – 2021-12-31: -41348000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ACORDA THERAPEUTICS INC · 2021-12-31 ACORDA THERAPEUTICS INC (edgar:1008848) Operating Cash Flow: -41348000 USD Concept: fundies:OperatingCashFlow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T16:57:15Z Snapshot: 748ac4fe79b8cf4dbe84212e0f2cc038fc8affdab4189df0d492e45d50522821 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1008848/explain?concept=fundies%3AOperatingCashFlow&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -41348000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1008848/000095017023007948/acor-20221231.htm#2153034 Filing: 000095017023007948 The citation records this snapshot. The page link may show a newer release later.	USD 165,000 Exact value Exact value: 165000 USD 2021-01-01 – 2021-12-31: 165000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ACORDA THERAPEUTICS INC · 2021-12-31 ACORDA THERAPEUTICS INC (edgar:1008848) Capital Expenditure: 165000 USD Concept: fundies:CapitalExpenditure Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T16:57:15Z Snapshot: 748ac4fe79b8cf4dbe84212e0f2cc038fc8affdab4189df0d492e45d50522821 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1008848/explain?concept=fundies%3ACapitalExpenditure&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 165000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1008848/000095017023007948/acor-20221231.htm#2160940 Filing: 000095017023007948 The citation records this snapshot. The page link may show a newer release later.	−USD 41.51 million Calculation and evidence -41348000 − 165000 USD Exact free cash flow: -41513000 USD 2021-01-01 – 2021-12-31: -41348000 USD · Inspect Operating Cash Flow · Source 2021-01-01 – 2021-12-31: 165000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ACORDA THERAPEUTICS INC · 2021-12-31 ACORDA THERAPEUTICS INC (edgar:1008848) Free cash flow: -41513000 USD Concept: free-cash-flow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T16:57:15Z Snapshot: 748ac4fe79b8cf4dbe84212e0f2cc038fc8affdab4189df0d492e45d50522821 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1008848?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -41348000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1008848/000095017023007948/acor-20221231.htm#2153034 Filing: 000095017023007948 Input fundies:CapitalExpenditure: 165000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1008848/000095017023007948/acor-20221231.htm#2160940 Filing: 000095017023007948 The citation records this snapshot. The page link may show a newer release later.
2022 2022-01-01 – 2022-12-31	−USD 65.92 million Exact value Exact value: -65916000 USD 2022-01-01 – 2022-12-31: -65916000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ACORDA THERAPEUTICS INC · 2022-12-31 ACORDA THERAPEUTICS INC (edgar:1008848) Net Income: -65916000 USD Concept: fundies:NetIncome Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T16:57:15Z Snapshot: 748ac4fe79b8cf4dbe84212e0f2cc038fc8affdab4189df0d492e45d50522821 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1008848/explain?concept=fundies%3ANetIncome&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:NetIncome: -65916000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1008848/000095017024039464/acor-20231231.htm#2929385 Filing: 000095017024039464 The citation records this snapshot. The page link may show a newer release later.	−USD 20.92 million Exact value Exact value: -20924000 USD 2022-01-01 – 2022-12-31: -20924000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ACORDA THERAPEUTICS INC · 2022-12-31 ACORDA THERAPEUTICS INC (edgar:1008848) Operating Cash Flow: -20924000 USD Concept: fundies:OperatingCashFlow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T16:57:15Z Snapshot: 748ac4fe79b8cf4dbe84212e0f2cc038fc8affdab4189df0d492e45d50522821 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1008848/explain?concept=fundies%3AOperatingCashFlow&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -20924000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1008848/000095017024039464/acor-20231231.htm#1655738 Filing: 000095017024039464 The citation records this snapshot. The page link may show a newer release later.	USD 136,000 Exact value Exact value: 136000 USD 2022-01-01 – 2022-12-31: 136000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ACORDA THERAPEUTICS INC · 2022-12-31 ACORDA THERAPEUTICS INC (edgar:1008848) Capital Expenditure: 136000 USD Concept: fundies:CapitalExpenditure Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T16:57:15Z Snapshot: 748ac4fe79b8cf4dbe84212e0f2cc038fc8affdab4189df0d492e45d50522821 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1008848/explain?concept=fundies%3ACapitalExpenditure&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 136000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1008848/000095017024039464/acor-20231231.htm#1660786 Filing: 000095017024039464 The citation records this snapshot. The page link may show a newer release later.	−USD 21.06 million Calculation and evidence -20924000 − 136000 USD Exact free cash flow: -21060000 USD 2022-01-01 – 2022-12-31: -20924000 USD · Inspect Operating Cash Flow · Source 2022-01-01 – 2022-12-31: 136000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ACORDA THERAPEUTICS INC · 2022-12-31 ACORDA THERAPEUTICS INC (edgar:1008848) Free cash flow: -21060000 USD Concept: free-cash-flow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T16:57:15Z Snapshot: 748ac4fe79b8cf4dbe84212e0f2cc038fc8affdab4189df0d492e45d50522821 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1008848?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -20924000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1008848/000095017024039464/acor-20231231.htm#1655738 Filing: 000095017024039464 Input fundies:CapitalExpenditure: 136000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1008848/000095017024039464/acor-20231231.htm#1660786 Filing: 000095017024039464 The citation records this snapshot. The page link may show a newer release later.
2023 2023-01-01 – 2023-12-31	−USD 252.85 million Exact value Exact value: -252854000 USD 2023-01-01 – 2023-12-31: -252854000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ACORDA THERAPEUTICS INC · 2023-12-31 ACORDA THERAPEUTICS INC (edgar:1008848) Net Income: -252854000 USD Concept: fundies:NetIncome Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T16:57:15Z Snapshot: 748ac4fe79b8cf4dbe84212e0f2cc038fc8affdab4189df0d492e45d50522821 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1008848/explain?concept=fundies%3ANetIncome&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:NetIncome: -252854000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1008848/000095017024039464/acor-20231231.htm#2928083 Filing: 000095017024039464 The citation records this snapshot. The page link may show a newer release later.	−USD 13.98 million Exact value Exact value: -13984000 USD 2023-01-01 – 2023-12-31: -13984000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ACORDA THERAPEUTICS INC · 2023-12-31 ACORDA THERAPEUTICS INC (edgar:1008848) Operating Cash Flow: -13984000 USD Concept: fundies:OperatingCashFlow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T16:57:15Z Snapshot: 748ac4fe79b8cf4dbe84212e0f2cc038fc8affdab4189df0d492e45d50522821 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1008848/explain?concept=fundies%3AOperatingCashFlow&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -13984000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1008848/000095017024039464/acor-20231231.htm#1654398 Filing: 000095017024039464 The citation records this snapshot. The page link may show a newer release later.	USD 264,000 Exact value Exact value: 264000 USD 2023-01-01 – 2023-12-31: 264000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ACORDA THERAPEUTICS INC · 2023-12-31 ACORDA THERAPEUTICS INC (edgar:1008848) Capital Expenditure: 264000 USD Concept: fundies:CapitalExpenditure Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T16:57:15Z Snapshot: 748ac4fe79b8cf4dbe84212e0f2cc038fc8affdab4189df0d492e45d50522821 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1008848/explain?concept=fundies%3ACapitalExpenditure&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 264000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1008848/000095017024039464/acor-20231231.htm#1659354 Filing: 000095017024039464 The citation records this snapshot. The page link may show a newer release later.	−USD 14.25 million Calculation and evidence -13984000 − 264000 USD Exact free cash flow: -14248000 USD 2023-01-01 – 2023-12-31: -13984000 USD · Inspect Operating Cash Flow · Source 2023-01-01 – 2023-12-31: 264000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ACORDA THERAPEUTICS INC · 2023-12-31 ACORDA THERAPEUTICS INC (edgar:1008848) Free cash flow: -14248000 USD Concept: free-cash-flow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T16:57:15Z Snapshot: 748ac4fe79b8cf4dbe84212e0f2cc038fc8affdab4189df0d492e45d50522821 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1008848?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -13984000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1008848/000095017024039464/acor-20231231.htm#1654398 Filing: 000095017024039464 Input fundies:CapitalExpenditure: 264000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1008848/000095017024039464/acor-20231231.htm#1659354 Filing: 000095017024039464 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

270 filings · 6,004 latest values · 6,004 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001008848, 1008848, ACOR, ACORQ, edgar:1008848

Also known as ACORDA THERAPEUTICS INC, ACORDA THERAPEUTICS INC , ACORDA THERAPEUTICS, INC., ACORDA THERAPEUTICS, INC., Acorda Therapeutics, Inc.

ACORDA THERAPEUTICS INC

Latest quarter

Revenue

Operating margin

Operating cash flow

Reported share-count change

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2023 2023-01-01 – 2023-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation